Announcements Trials
Browse Landscape

Phase

Phase 2 49Phase 1 20Phase 1/2 13Phase 3 5Phase NA 1Phase EARLY_PHASE1 1Phase 4 1

Status

Completed 26Recruiting 9Active not recruiting 8Terminated 5Unknown 4Not yet recruiting 1

Sponsor Class

OTHER 2NIH 1NETWORK 1INDUSTRY 1

Study Type

Interventional 5

Sponsor

Cancer Type

Breast 3Tumor-Agnostic 1Genitourinary 1

Conditions

Breast Neoplasms 3Neoplasms 1Carcinoma, Renal Cell 1

Interventions

Cisplatin 62Carboplatin 52Paclitaxel 48Radiotherapy 47Docetaxel 41Gemcitabine 38Cyclophosphamide 36Rituximab 33Capecitabine 28Fluorouracil 27Dexamethasone 27Doxorubicin 26Prednisone 21Bevacizumab 20Pemetrexed 19Oxaliplatin 18Leucovorin 18pembrolizumab 17Vincristine 17Etoposide 17Cytarabine 15Drug Therapy 14Irinotecan 13Imatinib Mesylate 13Filgrastim 13Zoledronic Acid 12Radiosurgery 12Erlotinib Hydrochloride 12Trastuzumab 11Goserelin 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 3 × Terminated × Everolimus × Clear all
NCT03839940 2025-01-29

MIST

Alliance for Clinical Trials in Oncology

Phase 3 Terminated
39 enrolled 18 charts
Tumor-Agnostic

Neoplasms

NCT05065411 2024-02-26

VERU-024

Veru Inc.

Phase 3 Terminated
5 enrolled
Breast

Breast Neoplasms

NCT02137837 2021-01-28

S1222 Trial (Everolimus, Anastrozole and Fulvestrant) in Post-Menopausal Stage IV Breast Cancer

SWOG Cancer Research Network

Phase 3 Terminated
37 enrolled 16 charts
Breast

Breast Neoplasms

NCT01198158 2019-03-06

Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy

National Cancer Institute (NCI)

Phase 3 Terminated
77 enrolled 11 charts
Genitourinary

Carcinoma, Renal Cell

NCT01773460 2016-02-10

Evelyn

GBG Forschungs GmbH

Phase 3 Terminated
3 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡